These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14768351)

  • 1. [Stability of nilvadipine solid dispersion tablet with non-packaging condition].
    Hirasawa N; Ishise S; Miyata H
    Yakugaku Zasshi; 2004 Jan; 124(1):19-23. PubMed ID: 14768351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of nilvadipine solid dispersion to tablet formulation and manufacturing using crospovidone and methylcellulose as dispersion carriers.
    Hirasawa N; Ishise S; Miyata H; Danjo K
    Chem Pharm Bull (Tokyo); 2004 Feb; 52(2):244-7. PubMed ID: 14758011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An attempt to stabilize nilvadipine solid dispersion by the use of ternary systems.
    Hirasawa N; Ishise S; Miyata H; Danjo K
    Drug Dev Ind Pharm; 2003 Oct; 29(9):997-1004. PubMed ID: 14606663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of medicines stored together in multi-compartment compliance aids.
    Donyai P
    J Clin Pharm Ther; 2010 Oct; 35(5):533-43. PubMed ID: 20831678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive evaluation of pharmaceutical properties of direct compression tablets containing theophylline anhydrate during storage at high humidity by near-infrared spectroscopy.
    Otsuka Y; Yamamoto M; Tanaka H; Otsuka M
    Biomed Mater Eng; 2015; 25(3):223-36. PubMed ID: 26407109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stability of probucol-polyvinylpyrrolidone solid dispersion systems].
    Kubo Y; Yagi N; Sekikawa H
    Yakugaku Zasshi; 2011 Apr; 131(4):629-34. PubMed ID: 21467803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of X-ray exposure on the pharmaceutical quality of drug tablets using X-ray inspection equipment.
    Uehara K; Tagami T; Miyazaki I; Murata N; Takahashi Y; Ohkubo H; Ozeki T
    Drug Dev Ind Pharm; 2015 Jun; 41(6):953-8. PubMed ID: 24842380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of moisture content, temperature and exposure time on the physical stability of chitosan powder and tablets.
    Viljoen JM; Steenekamp JH; Marais AF; Kotzé AF
    Drug Dev Ind Pharm; 2014 Jun; 40(6):730-42. PubMed ID: 23596972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of packaging and storage on the stability of carbamazepine tablets.
    al-Zein H; Riad LE; Abd-Elbary A
    Drug Dev Ind Pharm; 1999 Feb; 25(2):223-7. PubMed ID: 10065356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of Storage Conditions after One-dose Packaging on Stability of Magnesium Oxide Tablets].
    Sato K; Inaoka N; Kodama Y; Muro T; Nakamura T; Sasaki H; Kitahara T
    Yakugaku Zasshi; 2018; 138(11):1435-1441. PubMed ID: 30381651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of storage at specified temperature and humidity on properties of three directly compressible tablet formulations.
    Horhota ST; Burgio J; Lonski L; Rhodes CT
    J Pharm Sci; 1976 Dec; 65(12):1746-9. PubMed ID: 1032656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of physicochemical factors affecting the stability of a pH-modulated solid dispersion and a tablet during storage.
    Tran PH; Tran TT; Park JB; Min DH; Choi HG; Han HK; Rhee YS; Lee BJ
    Int J Pharm; 2011 Jul; 414(1-2):48-55. PubMed ID: 21565260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative stability of repackaged metoprolol tartrate tablets.
    Yang Y; Gupta A; Carlin AS; Faustino PJ; Lyon RC; Ellison CD; Rothman B; Khan MA
    Int J Pharm; 2010 Jan; 385(1-2):92-7. PubMed ID: 19879937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism by Which Magnesium Oxide Suppresses Tablet Hardness Reduction during Storage.
    Sakamoto T; Kachi S; Nakamura S; Miki S; Kitajima H; Yuasa H
    Chem Pharm Bull (Tokyo); 2016; 64(9):1256-61. PubMed ID: 27581629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of packaging and storage on the dissolution of model prednisone tablets.
    Taborsky-Urdinola CJ; Gray VA; Grady LT
    Am J Hosp Pharm; 1981 Sep; 38(9):1322-7. PubMed ID: 7282715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of storage on in-vitro release of ibuprofen from sugar coated tablets.
    Saville DJ
    Int J Pharm; 2001 Aug; 224(1-2):39-49. PubMed ID: 11472813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary study of the physical stability of tablets prepared from powders stored under tropical conditions.
    York P
    Pharmazie; 1976 Jun; 31(6):383-6. PubMed ID: 959298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging of tablets made with dibasic calcium phosphate dihydrate as matrix.
    Lausier JM; Chiang CW; Zompa HA; Rhodes CT
    J Pharm Sci; 1977 Nov; 66(11):1636-7. PubMed ID: 915749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of generic preparations of famotidine orally disintegrating tablets for use in unit-dose packages.
    Yamazaki N; Iizuka R; Miyazawa S; Wada Y; Shimokawa K; Ishii F
    Drug Discov Ther; 2012 Oct; 6(5):263-8. PubMed ID: 23229147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-state stability assessment of controlled release tablets containing Carbopol 971P.
    Goskonda VR; Reddy IK; Durrani MJ; Wilber W; Khan MA
    J Control Release; 1998 Jun; 54(1):87-93. PubMed ID: 9741906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.